Loading insider details...
Beta
Latest Form 4 (Sep 3, 2026): Exercise/Conversion of 9,991 KNSA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 3, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 9,991 | n/a |
| Sep 3, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 9,991 | n/a |
| Jun 2, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | Conversion | 900,000 | n/a |
| May 1, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 48,565 | $1.50M |
| Apr 30, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 431,904 | $4.47M |
| Apr 8, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 7,278 | $75.4K |
| Apr 3, 2026 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 21,327 | n/a |
| Nov 14, 2025 | Kiniksa Pharmaceuticals International, plc (KNSA) | Gift | 111,794 | n/a |
| Oct 22, 2025 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 121,248 | $460.7K |
| Sep 3, 2025 | Kiniksa Pharmaceuticals International, plc (KNSA) | Exercise/Conversion | 6,238 | n/a |